Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study

Active, not recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

September 21, 2017

Primary Completion Date

September 22, 2026

Study Completion Date

September 22, 2027

Conditions
Osteoporosis,Neurological Disorders
Interventions
COMBINATION_PRODUCT

Exercise,Nutrition,Bisphosphonates,Statins,Calcitonin,Vitamin D,et al.

The long-term effect of comprehensive treatment on health, especially for osteoporosis and neurodegenerative diseases, we hope to find association from epigenetics and provide clues for further exploration of its pathogenesis.

Trial Locations (1)

100191

Peking University Third Hospital, Beijing

All Listed Sponsors
collaborator

National Natural Science Foundation of China

OTHER_GOV

collaborator

Ministry of Education, China

OTHER_GOV

collaborator

Beijing Municipal Science & Technology Commission

OTHER

collaborator

Ministry of Science and Technology of the People´s Republic of China

OTHER_GOV

collaborator

Peking University Health Science Center

OTHER

lead

Peking University Third Hospital

OTHER

NCT03401619 - Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study | Biotech Hunter | Biotech Hunter